Acute Hemodynamic Effects of Conivaptan, a Dual V1A and V2 Vasopressin Receptor Antagonist, in Patients With Advanced Heart Failure
Circulation - United States
doi 10.1161/hc4501.099313
Full Text
Open PDFAbstract
Available in full text
Date
November 13, 2001
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)